Metanoantracenos as dopamine antagonists.

Compounds of formula I, and pharmaceutically acceptable salts CONSEQUEN useful in the treatment of disorders such as psychosis neuropsychiatric; Pharmaceutical compositions comprising a compound of formula IY A pharmaceutically acceptable carrier or diluent; AND METHODS FOR TREATING DISORDERS COMPRISING neuropsychiatric administering to a mammal (including humans) in need of such treatment an effective amount of a compound of formula I, or a pharmaceutically acceptable salt ACCORDINGLY.